NLS Pharmaceutics AG (NLSPW)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
0.01
-0.01 (-42.86%)
At close: Jan 15, 2025, 12:42 PM
0.01
0.00%
After-hours Jan 15, 2025, 12:42 PM EST
Income Statement (Annual)
Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 | FY17 |
Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 11.41K | 11.41K | 10.05K | n/a | n/a | n/a | n/a |
Gross Profit | -11.41K | -11.41K | -10.05K | n/a | n/a | n/a | n/a |
Operating Income | -11.81M | -15.48M | -11.86M | -2.30M | -4.20M | -3.45M | -5.77M |
Interest Income | n/a | 100.87 | 68.13 | 233.70 | 819.71 | 16.04K | 890.40 |
Pretax Income | -12.17M | -16.50M | -11.95M | -2.86M | -5.45M | -5.15M | -6.66M |
Net Income | -12.17M | -16.50M | -11.95M | -2.86M | -5.45M | -5.15M | -6.66M |
Selling & General & Admin | 5.90M | 6.49M | 5.93M | 2.20M | 2.49M | 2.01M | 1.44M |
Research & Development | 5.91M | 8.98M | 5.92M | 99.58K | 1.70M | 1.44M | 4.32M |
Other Expenses | 0.00 | 10.04K | -17.32K | -328.37K | n/a | -629.23K | n/a |
Operating Expenses | 11.81M | 15.47M | 11.85M | 2.30M | 4.20M | 3.45M | 5.77M |
Interest Expense | 145.15K | 100.87K | 68.13K | 233.70K | 819.71K | 1.07M | 890.40K |
Selling & Marketing Expenses | n/a | 6.49M | 5.93M | 2.20M | 2.49M | n/a | n/a |
Cost & Expenses | 11.81M | 15.48M | 11.86M | 2.30M | 4.20M | 3.45M | 5.77M |
Income Tax | n/a | 2.00 | -226.51K | -2.30K | -4.20K | 1.70M | -5.77K |
Shares Outstanding (Basic) | 38.18M | 19.68M | 14.75M | 4.82M | 11.14M | 11.78M | 11.78M |
Shares Outstanding (Diluted) | 38.18M | 19.68M | 14.75M | 4.82M | 11.14M | 11.78M | 11.78M |
EPS (Basic) | -0.32 | -0.84 | -0.81 | -0.59 | -0.49 | -0.44 | -0.57 |
EPS (Diluted) | -0.32 | -0.84 | -0.81 | -0.59 | -0.49 | -0.44 | -0.57 |
EBITDA | -11.80M | -15.47M | -11.85M | n/a | -430.40K | -613.20K | -5.77M |
Depreciation & Amortization | 11.41K | 11.41K | 10.05K | 2.30M | 4.20M | 3.45M | 5.77M |